Irlanda - inglese - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - bicalutamide - tablet - 50mg milligram(s) - anti-androgens; bicalutamide

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

astrazeneca ab - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

laboratoires juvise pharmaceuticals - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide

Israele - inglese - Ministry of Health

taro international ltd, israel - bicalutamide - tablets - bicalutamide 50 mg - bicalutamide - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.

Israele - inglese - Ministry of Health

astra zeneca (israel) ltd - bicalutamide - tablets - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) casodex 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Israele - inglese - Ministry of Health

teva israel ltd - bicalutamide - tablets - bicalutamide 50 mg - bicalutamide - bicalutamide - for the treatment of advanced prostate cancer in combination with lhrh analog therapy or surgical castration.

Israele - inglese - Ministry of Health

teva israel ltd - bicalutamide - tablets - bicalutamide 150 mg - bicalutamide - bicalutamide - in patients with locally advanced prostate cancer (t3-t4 any n m0 t1-t2 n+ m0) bicalutamide is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Israele - inglese - Ministry of Health

taro international ltd - bicalutamide 150 mg - film coated tablets - bicalutamide - in patients with locally advanced prostate cancer (t3 - t4 any n m0 t1 -t2 n+ m0) bicamide 150 mg is indicated as immediate therapy either alone or as adjuvant to treatment by radical prostatectomy or radiotherapy. the management of patients with locally advanced non-metastatic prostate cancer for whom surgical castration or other medical intervention is not considered appropriate or acceptable.

Israele - inglese - Ministry of Health

inovamed ltd - bicalutamide - film coated tablets - bicalutamide 50 mg - bicalutamide - bicalutamide - for the treatment of advanced prostate cancer in combination with luteinising hormone-releasing hormone (lhrh) analog therapy or surgical castration.